Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.

about

T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity.Mitochondrial Reactive Oxygen Species and Type 1 Diabetes.

P2860

Q39183146-634E9BCE-5F5E-4A66-9BB6-6EED76355AD6 Q49362193-33D46E0B-3F0A-436B-B803-12BB539C05A5

P2860

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.

Item

http://www.wikidata.org/entity/Q36987677

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.

@en

type

Item

label

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.

@en

prefLabel

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.

@en

P1476

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE

@en

P2093

Alex Stewart

http://www.w3.org/2001/XMLSchema#string

Jinxiu Rui

http://www.w3.org/2001/XMLSchema#string

Justin W Garyu

http://www.w3.org/2001/XMLSchema#string

Matt M Staron

http://www.w3.org/2001/XMLSchema#string

Mohamed Uduman

http://www.w3.org/2001/XMLSchema#string

Songyan Deng

http://www.w3.org/2001/XMLSchema#string

Steven H Kleinstein

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Posttranscriptional control of T cell effector function by aerobic glycolysis

Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.

Fueling immunity: insights into metabolism and lymphocyte function

Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells

Type 1 diabetes: translating mechanistic observations into effective clinical outcomes

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

lumi: a pipeline for processing Illumina microarray

Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase.

TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8+ T Cell differentiation.

P304

11230-11240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M115.713362

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

291

http://www.w3.org/2001/XMLSchema#string

P50

Jared A Shenson

Susan M Kaech

Kevan C Herold

P577

2016-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26994137

http://www.w3.org/2001/XMLSchema#string

P932

4900270

http://www.w3.org/2001/XMLSchema#string

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.

about

P2860

P2860

Characterization of Diabetogenic CD8+ T Cells: IMMUNE THERAPY WITH METABOLIC BLOCKADE.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932